Optimal treatment of diabetic retinopathy
Diabetic retinopathy (DRP) is a common complication caused by multiple biochemical abnormalities of the underlying metabolic disease. While the incidence of DRP appears to decline due to evidence-based changes in diabetes management, the predicted increase in patients affected in particular by type...
Main Author: | Hans-Peter Hammes |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2013-04-01
|
Series: | Therapeutic Advances in Endocrinology and Metabolism |
Online Access: | https://doi.org/10.1177/2042018813477886 |
Similar Items
-
Advancing Diabetic Retinopathy Research: Analysis of the Neurovascular Unit in Zebrafish
by: Chiara Simone Middel, et al.
Published: (2021-05-01) -
The role of insulin resistance in experimental diabetic retinopathy-Genetic and molecular aspects.
by: Patrick Järgen, et al.
Published: (2017-01-01) -
miRNA-124 Prevents Rat Diabetic Retinopathy by Inhibiting the Microglial Inflammatory Response
by: Ying Chen, et al.
Published: (2023-01-01) -
The DPP4 Inhibitor Linagliptin Protects from Experimental Diabetic Retinopathy.
by: Nadine Dietrich, et al.
Published: (2016-01-01) -
Glucosamine protects against neuronal but not vascular damage in experimental diabetic retinopathy
by: Rachana Eshwaran, et al.
Published: (2021-12-01)